← Return to Just approved: Evusheld for the pre-exposure prevention of COVID-19

Discussion

Just approved: Evusheld for the pre-exposure prevention of COVID-19

Transplants | Last Active: Aug 19, 2022 | Replies (173)
Comment receiving replies
@estrada53

It is approved - yes. At this point apparently Mayo is playing it safe with heart recipients.

Jump to this post

Replies to "It is approved - yes. At this point apparently Mayo is playing it safe with heart..."
Nancy Banks | @banksnc49 | Jan 19, 2022

Heart problems can be a side effect of Evusheld. I’m sure that’s why they’re being so careful.

VIEW AND REPLY